Afuco™ Anti-Human FGF23 ADCC Therapeutic Antibody (KRN23), ADCC Enhanced
Anti-FGF23 ADCC Enhanced Antibody (KRN23) is an ADCC enhanced antibody produced by our Afuco™ platform. KRN23 is a recombinant fully human monoclonal antibody against FGF23, in pediatric subjects with X-linked hypophosphatemia (XLH).
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-268CL |
| Pricing | Inquiry |
| Host | Human |
| Target | FGF23 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |